Headline and summary only
The publisher's terms don't allow us to store or analyse its articles, so Ask does not use this one and no take is written from it. Once other publishers report the story, a take written from their reporting appears here. The full story is on the publisher's site.
OpenAI acquires startup Orchestra Bio to beef up its biotech business
OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results.
Read the full article at TechCrunchRelated coverage
OpenAI acquires Orchestra Bio to bring AI agents into drug development
SiliconANGLE · Oct 20, 2026
OpenAI acquires Orchestra Bio
OpenAI · Oct 20, 2026
[AINews] DeepSeek DeepInfer: Open Source SOTA Inference running 155T toks/day/cluster making $22m/day at ~80% margin for a 81 day payback
Latent Space · Oct 21, 2026
Nonprofits are embracing AI to advance their missions, but few have a road map for adoption
Fortune · Oct 21, 2026